Picture supply: Getty Pictures
Ilika (LSE: IKA) makes solid-state batteries, and it may be purchased for penny share costs. Its know-how may very well be massive within the sort of distributed processing that may doubtless contribute to the way forward for AI — amongst a spread of different purposes.
As I write simply earlier than markets open on Tuesday (26 August), we’re a market cap of £72m and a 40p share value. That represents an 86% acquire simply for the reason that begin of 2025. However earlier than we expect an excessive amount of about what the long run may maintain, there’s one word of warning.
Again in 2021, the shares reached 280p. So anybody who purchased on the peak is now down 85% general — even after this yr’s acquire. However new tech like this typically wants a second wind to actually get began. And AI attracts extra consideration now than 4 years in the past.
What’s the joy?
On 18 August, Ilika introduced a milestone with US strategic associate Cirtec Medical, an organization creating next-generation medical units. The information launch stated: “The businesses have efficiently accomplished course of qualification for the Stereax M300 micro-battery manufacturing line at Cirtec Medical’s facility in Lowell, Massachusetts.”
This, apparently, is the ultimate technical validation wanted earlier than manufacturing can begin.
It comes after CEO Graeme Purdy informed us at full-year outcomes time in July that “Ilika has achieved a big variety of vital technical and industrial milestones over the previous twelve months.“
The corporate’s subsequent main strikes embody getting its electrical car battery know-how, Goliath, to viable product standing by the top of 2025, which implies finishing prototypes and getting them to prospects for testing.
We also needs to hopefully see the popularity of Stereax revenues start within the present calendar yr.
A no brainer purchase?
So, is it time to hurry out and purchase then?
Earlier than anybody considers it, there’s one key disadvantage — there’s no revenue. The yr ended 30 April noticed simply £1.1m in income, with an EBITDA lack of £5.2m.
However there was money and equivalents of £8m on the stability sheet on the time. After the top of the interval, the corporate raised £4.2m gross from a fundraising. And it obtained a £1.25m grant from the UK authorities’s DRIVE35 programme, which funds R&D in car electrification.
This all suggests there’s sufficient liquidity for some time but. However analysts nonetheless forecast losses for a minimum of the following two years. And so they see the money pile dwindling to round £1m by 2027.
It appears doubtless that Ilika may wish extra funding earlier than the revenue faucets open. And that would properly result in dilution for traders who make the leap in the present day.
The dilemma
This is identical dilemma that’s confronted numerous traders in potential high-tech progress shares whereas they’re nonetheless within the ‘jam tomorrow’ section. And for me, it normally means I steer clear and don’t think about shopping for till I see first revenue.
However on this case, primarily based on Stereax batteries hopefully producing gross sales within the close to time period, I’m truly pondering a small funding. I believe penny share progress traders ought to think about it too.
